Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Receives Consensus Recommendation of “Reduce” from Brokerages

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) has been given a consensus recommendation of “Reduce” by the nine analysts that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and eight have issued a hold rating on the company.

BAYRY has been the topic of several recent analyst reports. Wolfe Research downgraded shares of Bayer Aktiengesellschaft from an “outperform” rating to a “peer perform” rating in a research note on Tuesday, January 30th. Sanford C. Bernstein reissued a “market perform” rating on shares of Bayer Aktiengesellschaft in a research report on Thursday, March 7th. Finally, Citigroup restated a “neutral” rating on shares of Bayer Aktiengesellschaft in a research report on Thursday, February 29th.

Bayer Aktiengesellschaft Trading Down 0.5 %

Shares of OTCMKTS BAYRY opened at $7.68 on Thursday. The business has a fifty day simple moving average of $7.36 and a 200-day simple moving average of $8.49. The company has a market cap of $30.18 billion, a price-to-earnings ratio of -9.37 and a beta of 1.11. Bayer Aktiengesellschaft has a 12 month low of $6.96 and a 12 month high of $16.15. The company has a quick ratio of 0.80, a current ratio of 1.27 and a debt-to-equity ratio of 1.15.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last posted its quarterly earnings data on Tuesday, March 5th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.12. Bayer Aktiengesellschaft had a negative net margin of 6.31% and a positive return on equity of 17.27%. The company had revenue of $12.77 billion during the quarter. Sell-side analysts predict that Bayer Aktiengesellschaft will post 1.36 EPS for the current year.

Bayer Aktiengesellschaft Cuts Dividend

The business also recently declared a dividend, which will be paid on Monday, May 13th. Stockholders of record on Tuesday, April 30th will be paid a $0.0191 dividend. The ex-dividend date is Monday, April 29th. Bayer Aktiengesellschaft’s dividend payout ratio (DPR) is presently -2.44%.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.